Telangana, India

Ratnakar Aryasomayajula

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Biological E Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ratnakar Aryasomayajula. Retrieved from https://idiyas.com/inventor/ratnakar-aryasomayajula

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Ratnakar Aryasomayajula

Introduction

Ratnakar Aryasomayajula is a distinguished inventor based in Telangana, India. His innovative contributions to the field of pharmaceuticals are noteworthy, particularly his work on low molecular weight heparin. With one patent to his name, Aryasomayajula has made significant strides in enhancing medical treatments through his inventions.

Latest Patents

The primary patent held by Ratnakar Aryasomayajula is titled "Process for the Preparation of Low Molecular Weight Heparin." This patent presents an improved process for manufacturing Enoxaparin sodium, a widely used anticoagulant. The process he developed is characterized by its simplicity, commercial viability, and industrial advantages, making it an important advancement in pharmaceutical manufacturing.

Career Highlights

Ratnakar Aryasomayajula is associated with Biological E Limited, a company known for its commitment to innovation in biotechnology and pharmaceuticals. His work at this organization underscores his dedication to improving healthcare solutions through practical and efficient processes.

Collaborations

In his professional journey, Aryasomayajula has had the opportunity to work alongside talented individuals such as Manohar Sarma Vedula and Sreedhar Kosgi. These collaborations highlight his ability to work effectively within a team, contributing to innovative developments in the pharmaceutical industry.

Conclusion

Ratnakar Aryasomayajula exemplifies the spirit of innovation in the pharmaceutical field. With his patent for the preparation of low molecular weight heparin, he has laid the groundwork for future advancements in medical treatments. His contributions not only enhance the effectiveness of anticoagulant therapies but also illustrate the importance of intellectual property in fostering innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…